These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5769048)

  • 1. Erythrocyte sedimentation and soluble fibrin monomer complexes.
    Lipiński B; Worowski K; Myśliwiec M; Farbiszewski R
    Thromb Diath Haemorrh; 1969 Apr; 21(2):196-202. PubMed ID: 5769048
    [No Abstract]   [Full Text] [Related]  

  • 2. [Contents of soluble fibrin monomer complexes and fibrinogen in the plasma and erythrocyte sedimentation rate].
    Kleniewski J
    Pol Tyg Lek; 1971 Apr; 26(17):627-9. PubMed ID: 5092297
    [No Abstract]   [Full Text] [Related]  

  • 3. [The fibrinogen-fibrin-fibrinolysis system in rheumatoid arthritis].
    Belitskaia GA; Palienko IA; Shevchenko LI; Fedorova NE
    Vrach Delo; 1989 Jan; (1):47-50. PubMed ID: 2718445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of soluble fibrin monomer complexes in blood by means of protamine sulphate test.
    Lipiński B; Worowski K
    Thromb Diath Haemorrh; 1968 Nov; 20(1):44-9. PubMed ID: 4236938
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on plasma F. XIII subunit a level and the detection of soluble fibrin monomer in collagen diseases].
    Okubo S; Suzuki H; Ishida T; Yasunaga K
    Rinsho Ketsueki; 1986 Aug; 27(8):1339-44. PubMed ID: 3795511
    [No Abstract]   [Full Text] [Related]  

  • 6. Levels of soluble fibrin monomer complexes in the course of myocardial infarction.
    Nowak A; Lipiński B; Drzewiecki J
    Br Heart J; 1972 Jun; 34(6):593-6. PubMed ID: 5040258
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interaction of fibrinogen and fibrin with protamine sulfate].
    Mikhalovskaia LI; Varetskaia TV; Belitser VA
    Ukr Biokhim Zh (1978); 1988; 60(4):3-9. PubMed ID: 3188253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of trans-4-aminomethylcyclohexane carboxylic acid as an antifibrinolytic agent on arterial wall and experimental atherosclerotic lesions in rabbits.
    Kato N; Morimatsu M; Tanaka K; Horie A
    Thromb Diath Haemorrh; 1970 Oct; 24(1):85-99. PubMed ID: 5483976
    [No Abstract]   [Full Text] [Related]  

  • 9. Laboratory identification of intravascular coagulation. The serial dilution protamine sulfate test for the detection of fibrin monomer and fibrin degradation products.
    Niewiarowski S; Gurewich V
    J Lab Clin Med; 1971 Apr; 77(4):665-76. PubMed ID: 4928905
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnostic value of clinico-biological indices in infectious nonspecific polyarthritis].
    Vishnevskaya IT; Balaban SIa
    Sov Med; 1971 Nov; 34(11):77-82. PubMed ID: 5160642
    [No Abstract]   [Full Text] [Related]  

  • 11. [Soluble fibrin monomer complexes in thromboembolism].
    Gryglik J
    Przegl Lek; 1982 Sep; 39(8):551-3. PubMed ID: 6753042
    [No Abstract]   [Full Text] [Related]  

  • 12. [Characteristics of nonenzymatic fibrinolytic activity and the formation of adrenaline-heparin and noradrenaline-heparin complexes in the blood in logoneurosis].
    Podol'skaia OV; Shklovskii VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(5):711-5. PubMed ID: 4718614
    [No Abstract]   [Full Text] [Related]  

  • 13. [Soluble complexes of fibrin monomers (SFMC) in arterial hypertension].
    Zola-Sleczek E; Szczepaniec M
    Pol Tyg Lek; 1974 Feb; 29(6):213-6. PubMed ID: 4820174
    [No Abstract]   [Full Text] [Related]  

  • 14. [Soluble fibrin and fibrinogen degradation products in the blood of patients with rheumatoid arthritis].
    Starchurska J; Szpilman H; Latallo ZS; Kopeć M
    Reumatologia; 1972; 10(4):303-13. PubMed ID: 4645479
    [No Abstract]   [Full Text] [Related]  

  • 15. GPR-phoresis, a novel approach to determining fibrin monomer and other macromolecular derivatives of fibrinogen and fibrin in blood.
    Shainoff JR; Urbanic DA; DiBello PM; Valenzuela V
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):87-92. PubMed ID: 8457658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [comparison of indices of the blood rheological status in chronic ischemic heart disease].
    Furkalo NK; Progonnaia VV; Bol'shakova RM; Kuts' VA; Romanenko AI
    Vrach Delo; 1982 May; (5):37-41. PubMed ID: 7115523
    [No Abstract]   [Full Text] [Related]  

  • 17. New method to prepare autologous fibrin glue on demand.
    Alston SM; Solen KA; Broderick AH; Sukavaneshvar S; Mohammad SF
    Transl Res; 2007 Apr; 149(4):187-95. PubMed ID: 17383592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of an inhibitor of fibrinolysis upon the intravascular clearance of fibrin monomer in dogs.
    Pratt HW; Celander DR
    J Am Osteopath Assoc; 1970 Jun; 69(10):1049-50. PubMed ID: 5201432
    [No Abstract]   [Full Text] [Related]  

  • 19. Soluble fibrin complexes and fibrinogen heterogeneity in diabetes mellitus.
    Tsianos EB; Stathakis NE
    Thromb Haemost; 1980 Dec; 44(3):130-4. PubMed ID: 6162208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the origin of the proteolytic activity responsible for the release of fibrinogen-fibrin related antigen in vitro.
    Johnson AJ; Merskey C
    Scand J Haematol Suppl; 1971; 13():87-9. PubMed ID: 5290707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.